EUDA Health Holdings Ltd (EUDAW) EBITDA (2022 - 2023)
EUDA Health Holdings' (EUDAW) quarterly EBITDA came in at -$738974.0 in Q2 2023, up 64.7% year-on-year from -$448686.3 in Q2 2022, and up 62.62% on a QoQ basis from -$2.0 million in Q1 2023.
EUDA Health Holdings Ltd (EUDAW) EBITDA (2022 - 2023) Analysis & Trends
EUDA Health Holdings (EUDAW) has 2 years of EBITDA data on file, last reported at -$738974.0 in Q2 2023.
- On a quarterly basis, EBITDA rose 64.7% year-over-year to -$738974.0 in Q2 2023; TTM through Jun 2023 was -$14.5 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$2.5 million, up 85.71% from the prior year.
- EBITDA for Q2 2023 stood at -$738974.0, up from -$2.0 million in the prior quarter.
- Over the last five years, EBITDA for EUDAW reached as high as $75312.0 in Q1 2022 and fell as low as -$11.5 million in Q4 2022.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -738,974.00 |
| Mar 31, 2023 | -1.98 Mn |
| Dec 31, 2022 | -11.47 Mn |
| Oct 31, 2022 | -298,331.00 |
| Jun 30, 2022 | -2.09 Mn |
| Mar 31, 2022 | 75,312.00 |